Abstract: Disclosed are various embodiments that facilitate efficient pairing of mixed-reality devices using gaze tracking. In one embodiment, a host device and at least one client device are identified from a plurality of computing devices. A key sequence cue is communicated to a first user via the host device. A graphical display is simultaneously presented via each of the computing devices with a plurality of indicia distributed across the graphical display. Eye gazes of the first user and at least one second user are tracked using a respective gaze tracking sensor of the computing devices. The eye gaze traces a sequence of a subset of the indicia corresponding to the key sequence cue. A cryptographic key is generated based at least in part on the eye gaze of the first user and the second user(s).

Abstract: Embodiments of the present disclosure introduce approaches for protecting bystander privacy in a wearable augmented reality (AR) device. In one embodiment, a video frame is captured via a camera of the wearable AR device, and faces are detected in the video frame. A first face is classified as a subject based at least in part on eye gaze tracking of a user of the wearable AR device by an eye gaze sensor of the wearable AR device. A second face is classified as a bystander based at least in part on the eye gaze tracking of the user. The second face is obscured in the video frame in response to the second face being classified as the bystander.

Abstract: The invention relates to compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein: A is a moiety of formula: and to pharmaceutically acceptable salts and solvates thereof, wherein X, Z, D, E, V, W, Y, R1, R2, R5, R6, L, and u are as defined herein. The invention also relates to methods of treating abnormal cell growth in mammals by administering the compounds of formula I to a patient in need thereof, and to compositions for treating such disorders which contain the compounds of formula I. The invention also relates to methods of making the compounds of formula I.